A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction

INTRODUCTION: Targeted therapies using epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients harboring EGFR mutations, leading to the approval of gefitinib and erlotinib as standard first-line clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xuanxuan, Zhang, Junru, Guo, Guilong, Cai, Yuepiao, Cui, Ri, Yin, Changtian, Liu, Weidong, Vinothkumar, Rajamanickam, Zhang, Tingting, Liang, Guang, Zhang, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124478/
https://www.ncbi.nlm.nih.gov/pubmed/30214301
http://dx.doi.org/10.2147/CMAR.S159660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124478/
https://www.ncbi.nlm.nih.gov/pubmed/30214301
http://dx.doi.org/10.2147/CMAR.S159660

Ejemplares similares